FDA medical device loophole could cause patient harm, study warns

Further guidance is needed to protect patients from “sycophantic” genAI documentation outputs that influence medical decisions, and researchers are asking the FDA “to clarify its oversight before summarization becomes a part of routine patient care.”

Powered by WPeMatico